COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

Author:

Ahiakpa John K.ORCID,Cosmas Nanma T.ORCID,Anyiam Felix E.ORCID,Enalume Kingsley O.,Lawan Ibrahim,Gabriel Ijuptil B.,Oforka Chinonyelum L.,Dahir Hamze G.,Fausat Salisu T.ORCID,Nwobodo Maureen A.ORCID,Massawe Getrude P.,Obagha Adachukwu S.ORCID,Okeh Debra U.,Karikari BenjaminORCID,Aderonke Samuel T.,Awoyemi Olushola M.ORCID,Aneyo Idowu A.,Doherty Funmilayo V.

Abstract

Introduction The willingness of Africa’s population to patronise the COVID-19 vaccines is critical to the efficiency of national immunisation programmes. This study surveys the views of adult African inhabitants toward vaccination and the possibility of participating or not participating in governments’ efforts to get citizens vaccinated. Method A cross-sectional online survey of adult Africans was undertaken from December 2020 to March 2021. Responses were anonymised. The Pearson Chi-square test was performed to determine whether or not there were any variations in knowledge, awareness, perception and acceptance of the COVID-19 vaccines among the participants. Binomial logistic regression was used to evaluate the factors associated with willingness to accept the COVID-19 vaccines and participate in immunisation programmes. Results The results indicate that COVID-19 vaccines are more likely to be used by adult Africans over the age of 18 who are largely technologically savvy (55 percent) if the vaccine is made broadly available. A total of 33 percent of those who responded said they were unlikely to receive the vaccine, with another 15 percent stating they were undecided. Aside from that, we found that vaccine hesitancy was closely associated with socio-demographic characteristics such as age, gender, education and source of information. We also found that there were widespread conspiracies and myths about the COVID-19 vaccines. Conclusion More than one-third of African adults who participated in the survey indicated they would not receive the COVID-19 vaccine, with majority of them expressing skepticisms about the vaccine’s efficacy. It is possible that many of the people who would not be vaccinated would have an impact on the implementation of a COVID-19 immunisation programme that is meant for all of society. Majority of the respondents were unwilling to pay for the COVID-19 vaccines when made available. An awareness campaign should be focused on promoting the benefits of vaccination at the individual and population levels, as well as on taking preemptive actions to debunk misconceptions about the vaccines before they become further widespread.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China.;I Hui DS;International Journal of Infectious Diseases,2020

2. WHO. Coronavirus disease 2019 (COVID-19) Situation Report-86. 2020. Available: https://www.who.int/teams/risk-communication/infodemic-management

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin;P Zhou;Nature,2020

4. Genomic characterisation of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.;JFW Chan;Emerging Microbes & Infections.,2020

5. Structural insights into coronavirus entry;MA Tortorici;Advances in Virus Research,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3